MAIYESHIA MCFADDEN: Open Payments
NPI 1356673164 · BETHESDA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,579 in 60 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $211 · 2025 $1,579
Food & beverage: $1,509Education: $70
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $404 |
| Actelion Pharmaceuticals US, Inc. | 8 | $208 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $166 |
| PFIZER INC. | 7 | $137 |
| Medtronic, Inc. | 1 | $108 |
| E.R. Squibb & Sons, L.L.C. | 4 | $78 |
| Inspire Medical Systems, Inc. | 2 | $69 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
| Esperion Therapeutics, Inc. | 3 | $62 |
| Boston Scientific Corporation | 1 | $54 |
Products named: Wegovy, JARDIANCE, OPSUMIT, SYMPLICITY G3, ELIQUIS, VYNDAQEL, INSPIRE, NEXLETOL.
Industry payments across MD — which companies pay providers there.
